Imricor Names German University Hospital as Second Site for Heart Procedure Trial; Shares Rise 4%

MT Newswires Live

2025/12/19

Imricor Medical Systems (ASX:IMR) said Charite University Hospital in Berlin will serve as the second site of its clinical trial evaluating real-time magnetic resonance imaging-guided ventricular ablation, according to a Friday filing with the Australian bourse.

The so-called VISABL-VT trial launched in Amsterdam in April with the first-in-human ventricular ablation guided by real-time magnetic resonance imaging with the company's NorthStar mapping system, the company said in an April statement.

The company also expects to start atrial flutter ablations at the site in the first quarter of 2026, the filing said.

Shares of the company rose 4% in recent Friday trade.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2592332401"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2592332401\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2592332401?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-19 08:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592332401","market":"hk","top_or_hot":-1,"title":"Imricor Names German University Hospital as Second Site for Heart Procedure Trial; Shares Rise 4%","media":"MT Newswires Live","content":"<html><body><p> Imricor Medical Systems (ASX:IMR) said Charite University Hospital in Berlin will serve as the second site of its clinical trial evaluating real-time magnetic resonance imaging-guided ventricular ablation, according to a Friday filing with the Australian bourse.</p><p>The so-called VISABL-VT trial launched in Amsterdam in April with the first-in-human ventricular ablation guided by real-time magnetic resonance imaging with the company's NorthStar mapping system, the company said in an April statement.</p><p>The company also expects to start atrial flutter ablations at the site in the first quarter of 2026, the filing said.</p><p>Shares of the company rose 4% in recent Friday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Imricor Names German University Hospital as Second Site for Heart Procedure Trial; Shares Rise 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nImricor Names German University Hospital as Second Site for Heart Procedure Trial; Shares Rise 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-19 08:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Imricor Medical Systems (ASX:IMR) said Charite University Hospital in Berlin will serve as the second site of its clinical trial evaluating real-time magnetic resonance imaging-guided ventricular ablation, according to a Friday filing with the Australian bourse.</p><p>The so-called VISABL-VT trial launched in Amsterdam in April with the first-in-human ventricular ablation guided by real-time magnetic resonance imaging with the company's NorthStar mapping system, the company said in an April statement.</p><p>The company also expects to start atrial flutter ablations at the site in the first quarter of 2026, the filing said.</p><p>Shares of the company rose 4% in recent Friday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7503","symbol_name":"科技股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2592332401","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592332401","pubTimestamp":1766105477,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Imricor Medical Systems  said Charite University Hospital in Berlin will serve as the second site of its clinical trial evaluating real-time magnetic resonance imaging-guided ventricular ablation, according to a Friday filing with the Australian bourse.The so-called VISABL-VT trial launched in Amsterdam in April with the first-in-human ventricular ablation guided by real-time magnetic resonance imaging with the company's NorthStar mapping system, the company said in an April statement.The company also expects to start atrial flutter ablations at the site in the first quarter of 2026, the filing said.Shares of the company rose 4% in recent Friday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7503":"科技股","IMR.AU":"IMRICOR MEDICAL SYSTEMS-CDI","BK7508":"医药生物股","BK7007":"医疗保健设备"},"translate_title":"Imricor指定德国大学医院为心脏手术试验的第二个地点；股价上涨4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IMR.AU":1},"content_text":"Imricor Medical Systems (ASX:IMR) said Charite University Hospital in Berlin will serve as the second site of its clinical trial evaluating real-time magnetic resonance imaging-guided ventricular ablation, according to a Friday filing with the Australian bourse.The so-called VISABL-VT trial launched in Amsterdam in April with the first-in-human ventricular ablation guided by real-time magnetic resonance imaging with the company's NorthStar mapping system, the company said in an April statement.The company also expects to start atrial flutter ablations at the site in the first quarter of 2026, the filing said.Shares of the company rose 4% in recent Friday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}